Trial Search Results

Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

This clinical trial studies how well yttrium Y 90 glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors. Images produced by PET/CT may provide better information about the distribution of particles, such as yttrium Y 90 glass microspheres, delivered for selective internal radiation therapy (SIRT) compared to the technetium Tc-99m albumin aggregated single photon emission computed tomography (SPECT)/CT images.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Procedure: Computed Tomography (CT)
  • Procedure: Positron Emission Tomography (PET)
  • Device: 90-Yttrium (Y-90) Glass Microspheres
  • Diagnostic Test: Technetium 99mTc albumin aggregated (99mTc-MAA)
  • Procedure: Single-photon emission computerized tomography (SPECT) scan




Inclusion Criteria:

   - Patient provides written informed consent

   - Patient is referred for 90Y SIRT radioembolization of liver tumor(s)

   - Patient is capable of complying with study procedures

   - Patient is able to remain still for duration of imaging procedure (approximately 30
   minutes total for digital PET/CT)

Exclusion Criteria:

   - Patient is pregnant or nursing

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Risa Jiron